Fetroja

(Cefiderocol)

Fetroja

Drug updated on 11/14/2023

Dosage FormInjection (intravenous; 1 g/vial)
Drug ClassCephalosporin antibacterials
Ongoing and Completed StudiesClinicalTrials.gov

Indication

  • Indicated in patients 18 years of age or older who have limited or no alternative treatment options, for the treatment of complicated urinary tract infections (cUTI), including pyelonephritis caused by susceptible Gram-negative microorganisms.
  • Indicated in patients 18 years of age or older who have limited or no alternative treatment options, for the treatment Hospital-acquired Bacterial Pneumonia and Ventilator-associated Bacterial Pneumonia (HABP/VABP).